“Korea Rise: New Strategies Transforming Korean Biopharma and Unparalleled Opportunities for Collaboration”

September 27th (Tuesday), 2016
1:00 – 5:00 PM
Yale Club Manhattan, Trumbull Room 18th FL


1:00-1:30 PM Luncheon Reception  

1:00-1:35 PM Opening Statment 

DoHyun Cho, PhD

CEO and President, W Medical Strategy Group / Chairman, New York Health Forum

1:35-1:40 PM Congratulatory Remark 
Ki Young Sohn, CEO and Chairman, Enzychem Lifesciences

1:45-2:45 PM Session 1
“Collaboration status, strategies, and cases: Korean and Global pharma” 


Kimberly Ha, Senior Director, FTI Consulting (Moderator)
Han Bang, Director, CMIC USA
Tae Sik Han, Director, KOTRA
Judith Kim , Chair of IP Practice, Rubin and Rudman, LLP
S.H. Hwang , Director, Pfizer, USA

“Competitiveness of Chungbuk Province as a Biopharma Hub” 

Joe McManemin, MD, JD, EVP, W Medical Strategy Group (Moderator)


2:45-2:50 PM Special Remark
Honorable Mun-Sik Seol, Vice Governor of Chungbuk Province
2:50-3:15 PM Special Presentation
Jungmee, Sohn, PhD, Chungbuk Province


3:45-4:45 PM Session 2 
“Key trends of Global biopharma: Collaboration and beyond” 


Joe McManemin, MD, JD, EVP, W Medical Strategy Group (Moderator)
Alexander Fleming, MD, CEO, Kinexum
Les Funtleyder, Portfolio Manager, E Squared Partner
Rich Poska, PharmD, CEO, Flexo, LLC
Marc Ullman, Of Counsel, Rivkin Radler Law firm

forum_6th_01a forum_6th_01b forum_6th_01c

3:20 -3:40 PM Networking Break

4:40 PM- Closing

New York Health Forum (NYHF) is founded to strengthen healthcare partnerships and knowledge sharing at all levels, including industry, academia, medical and research facilities, service providers and financial investors. New York Health Forum’s mission is to present the significant agendas for healthcare industry, to contribute to public health by bringing out the public concerns to be discussed and solved; and to gather the sound of health policy, science innovation and industry development. Our 6th New York Health Forum’s title is “Korea Rise: New Strategies Transforming Korean Biopharma and Unparalleled Opportunities for Collaboraion” This forum will provide the setting for stimulating and informative discussions on the investment trends, landscapes, risks, and more. Around one hundred of investors, biopharma and medtech representatives, healthcare professionals will come together to connect, learn, and share.